Ocriplasmin Approved for VMT and Macular Holes

  Ocriplasmin, or Jetrea,  has been FDA approved.  The drug is approved only for a retinal condition called vitreomacular traction (VMT) or vitreomacular adhesion (VMA).  The VMT may or may not be associated with a macular hole. What is VMT? VMT is basically an incomplete, or partial, PVD (posterior vitreous detachment) with subsequent “pulling” on [...]

Full Story →